Division of Transfusion Medicine

Specialist in Blood Banking Technology (SBB) Program

Blood Bank Refrigerator
Program Overview +
The Johns Hopkins Hospital Specialist in Blood Bank Technology program is a work-study, graduate-level training program for ASCP-certified Medical Technologists with at least 2 years of full-time Blood Bank experience. The student is considered a full-time employee of the Johns Hopkins Hospital and is paid the salary of a Clinical Laboratory Scientist III.

The variety of patients, the size, and the general intellectual environment of the hospital provide excellent opportunities for training in Blood Banking. It is a challenging program that will prepare competent and knowledgeable graduates who will be able to effectively apply practical and theoretical skills in a variety of employment settings. Students are exposed to all areas of Transfusion Medicine including education, administration and research with supplemental rotations to the Immunogenetics and Cell Therapy Laboratories.
Program Outcome +
- 3 year SBB ASCP certification pass rate: 100%
- 5 year SBB ASCP certification pass rate: 100%
- 5 year Positive Placement: 100%
Application Evaluation +
The SBB Admissions Committee will evaluate all completed application packets for possible admission into the JHH SBB Program. The minimum requirements are:

1. Statement of Intent and Expectations
2. Resume/Curriculum Vitae- must have at least 2 years of Blood Bank experience with continuing education documentation
3. Professional References (3)
4. Official College Transcripts- 3.0 GPA preferred, 2.5 GPA accepted

The Admissions Committee evaluates the completed admissions packet and a determination is made as to the need for a personal interview. If an interview has been granted, the Education Coordinator will arrange for a mutually convenient appointment. Following the interview of each applicant, the faculty will rate the candidates according to academic ability, job experience, interview skills, career goals, and potential to complete the SBB program. These ratings will assist in the admissions process.

Those who have been accepted for admission to the SBB program will be phoned to offer the position. Written notification of acceptance will follow. Those not accepted for admission are sent letters of non-acceptance. Letters will not be sent to individuals who have failed to submit a complete informational record and who have been notified previously of an incomplete application.

Deadline for Applications is November 30 for admission in September of the following year.

Mail applications to:
     The Education and Development Coordinator
     Transfusion Medicine Division
     Sheikh Zayed Tower
     Room 3100 F
     The Johns Hopkins Hospital
     1800 Orleans Street
     Baltimore, Maryland 21287
Objectives and Competency Requirements +
Program Objectives*
*Adapted from CAAHEP Standards and Guidelines

A student admitted into the JHH SBB program will be educated to:
1. Develop technical and supervisory competencies in immunohematology, blood component manufacturing, and transfusion medicine.
2. Function as managers, educators, researchers, or technical consultants.
3. Work as part of the health care team in providing health services to patients.

Program Competency Statements*
*Adapted from CAAHEP Standards and Guidelines

An individual who seeks to fulfill the role of an SBB must be able to:
1. Determine and implement the appropriate procedures for recruiting, collecting, processing, labeling, storing, and distributing of allogeneic blood components and special collections, which include autologous, directed, apheresis, therapeutic stem cell, and bone marrow.
2. Provide safe, pure, potent, and effective blood components.
3. Select, utilize and evaluate current methodologies for the detection and identification of red cell, platelet, and leukocyte specific antigens and antibodies.
4. Evaluate laboratory results of hemostatic disorders including comprehensive diagnostic testing for bleeding, thrombotic and fibrinolytic disorders; correlate test results and provide consultation as an aid to physician diagnosis.
5. Provide guidance and leadership in administrative matters. These matters include billing and business records, purchasing, maintenance of supplies, general business procedures, workload recording, quality management and human resource responsibilities.
6. Understand and apply guidance and leadership for regulatory licensure and accreditation issues including current Good Manufacturing Practices, safety, and quality assurance.
7. Demonstrate professional conduct and interpersonal communication skills with patients, laboratory personnel, other health care professionals, and the public.
8. Understand and apply consultation for patients in need of transfusion regarding the appropriate indications for blood component therapy, handling of various components, and means of monitoring the efficacy of transfusion.
9. Apply sound principles of scientific research and educational methodology.
Student Evaluation Policy +
Students are continually monitored for both their work and academic performance. The Education Coordinator performs an informal evaluation after approximately three months of matriculation. Formal evaluations are conducted after six and twelve months. All SBB program faculty have input into these formal evaluations for both work and academic performance. Students will be evaluated by the instructors from each of the enhancement rotations and have the opportunity to evaluate the efficacy of each enhancement rotations.

The student's academic progress is evaluated formally by written examination and rotational evaluations. A grade of 80% or better on a research project and all written and practical exams should be achieved.

During the year, students are allotted time to perform a research project. This project must be written, using the same publication format as Transfusion, and submitted to the SBB faculty for review before graduation. In addition, the students will be required to present their project finding to their colleagues in the Transfusion Medicine Division. The student must achieve a grade of B or better on this project.

For all exams, the student must correct questions answered erroneously by documenting the source of the correct answer and why it is the correct answer. The Education Coordinator determines the need for a make-up exam after reviewing and discussing the exam with the student. The make-up exam may be for one or more subject areas in which the student has obtained a score of 80% or less, or for a subject area in which the student scored above 80% but does not demonstrate functional understanding of the subject area. A final practical exam will be given to evaluate the student's ability to solve complex serological problems. The number of specimens will be determined, and a score of 90% or better must be achieved. One additional specimen similar to those tested will be provided for a student who scores less than 90% on the practical. The score on this repeat testing must again be 90% or higher. The enhancement rotation technical instructor will evaluate the student during each rotation.

Students are required to complete all the objectives of the rotation as well as receive an overall average rating of no less 3. Students may be required to repeat the rotation at the discretion of the SBB Coordinator and the supervising technologist. The Education Coordinator will address any deficiencies detected in the rotational evaluations with the student.

Informal evaluations of the student's academic progress are monitored throughout the year by the TMD faculty. This is accomplished through observation of the student's daily work performance to include serological problem solving, management of problem situations, performance on the student project, and participation in tutorials, seminars, and journal clubs.

Students are strongly encouraged to discuss any problems they are having with laboratory work, or academic studies with the Education Coordinator. Other SBB faculty members are also available for discussion as well.

Students who successfully complete the SBB program will receive a Certificate of Completion and are expected to sit for the ASCP BOR SBB certification exam. The SBB Program and working environment of the JHH TMD provide a great deal of structure for the student. A successful year will require the student to be well organized on both their work and study time.
Didactic Lecture and Practical Requirements for Graduation +
The topics listed below will be addressed in scheduled lectures, journal clubs, case study reviews, lunch tutorials, continuing education conferences, and rotations (see descriptions on next link).

The student must have achieved acceptable grades and evaluation scores, as noted, for the following didactic and practical curricula:

A. Blood Procurement/Product Manufacturing
1. marketing/recruitment*
2. suitability*
3. collection*
4. reactions
5. testing - to include confirmatory testing*
6. donor notification, re-entry and look-back protocols
7. component preparation including special products*
8. labeling/storage*
9. inventory management *
10. special collections - to include autologous and directed donations*, therapeutic phlebotomy*, hemapheresis*, stem cell*, and bone marrow collections

B. Immunohematology and Specialized Laboratory Testing
1. genetics
2. immunology
3. molecular biology*
4. blood groups (history, chemistry, genetics, antibodies)
5. red blood cell testing methodologies*
6. histocompatibility and tissue typing
7. platelets and granulocyte testing
8. hematopoietic progenitor cell processing*
9. parentage testing
10. hemostasis and thrombosi

C. Transfusion Medicine Practice
1. physiology, composition and function of blood
2. survival of transfused cells
3. immune mechanisms of red cell destruction
4. anemias (clinical aspects, laboratory investigation and principles of management)
5. platelet disorders
6. leukopoiesis disorders
7. hemostatic and thrombotic disorders
8. blood component therapy*
     a. indications
     b. selection
     c. administration
     d. adverse reactions/complications
     e. evaluations
9. HDN
10. special transfusion:
     a. open heart surgery, massive, neonatal and pediatric
     b. intraoperative blood salvage
     c. oncological and transplantation support
11. blood substitutes and growth factors
12. therapeutic apheresis*

D. Quality Systems/Process Control
1. audits/assessments*
2. quality systems/ quality plan*
3. Current Good Manufacturing Practices (cGMP)*
4. regulations, standards, licensure and accreditation :AABB, CAP CLIA, FDA, ISHAGE (International Society for Hematopoietic and Graft Engineers), NCCLS, JCAHO, NRC (Nuclear Regulatory Commission),OSHA, and State
5. SOP and records management*
6. errors and accidents and risk management

E. Education and Research
1. competency evaluation*
2. proficiency testing
3. technical writing*
4. independent research*
5. education and training theory/techniques*
6. evaluation and outcomes assessment*
7. literature critique*
8. presentation skills*
F. Management and Administration

1. management theory
2. human resource management
3. financial management
4. information systems management
5. ethics and medical/legal considerations
6. quality management system

G. Presentations and Project
1. Present at least three critiques of current transfusion medicine journal articles.
2. Present at least three continuing education presentations
3. Research Project

CAAHEP Standards and Guidelines for an Accredited SBB Program
(Rev. 2000) * Supervised practice curriculum
Lecture Descriptions +
Tutorial Sessions - Monday, 3pm - 4pm
The Education Coordinator proctors each session and asks each student a few questions based on the assigned readings. As the year progresses, the student will assume the responsibility for asking questions. This forum provides an excellent opportunity for discussion of the topics in an informal manner. Textbooks used during these sessions may include but are not limited to: AABB Technical Manual, AABB Standards, Scientific Basis of Transfusion Medicine Implications for Clinical Practice by Ness and Anderson, Transfusion Reactions, Second Edition by Popovsky, and Ethical Issues in Transfusion Medicine by Macpherson, Domen, and Perlin.

Didactic Lecture - Tuesday & Thursday, 3pm - 4pm
TMD faculty members, senior staff of the TMD, and visiting lecturers, provide these lectures. Students are provided objectives as a guide for each topic and are expected to supplement the lecture presentation with additional readings.

Journal Club - Tuesday, 3pm - 4pm
Students orally present a critique of at least three current transfusion medicine journal articles of their choice. These sessions allow the student to become familiar with library resources, to become familiar with current research in the field of transfusion medicine, to develop the ability to critique and evaluate research, and to establish a basis for development and evaluation of the student research project.

Case Study Review - Wednesday, 3pm - 4pm
At least once a month, students will discuss the resolution of serologically complex cases. The cases will gradually progress from relatively easy to very difficult. Each student will present a case of his or her choice by the end of the academic year.

Continuing Education Lectures - Wednesday, 3pm - 4pm
These lectures are designed to help fulfill continuing education requirements for the entire TMD staff. Lectures may be presented on Blood Bank or related topics by TMD staff, Department of Pathology faculty, or staff members from other departments within the institution. SBB students are required to make at least three presentations in this forum to include: a joint lecture with another SBB student on a topic of mutual interest, an individual lecture on a topic of the student's choice, and a presentation of their research project.

Research Project
During the year, students are allotted time to perform a research project. This project must be written, using the same publication format as Transfusion, and submitted to the SBB faculty for review before graduation. Limited time is allowed for this project and should be well planned in advance. A faculty advisor is assigned to work with each student, however, it is the student's responsibility to determine the amount of time needed, the type and volume of reagents, and other resources needed to complete the project.

Rotations and Outside Activities
Students will receive schedules and objectives for their rotations to areas outside of the TMD. If a student is unable to attend a scheduled rotation, they notify the Education Coordinator. Students are expected to follow the directions of their instructor and the policies of the area in which they are rotating.
Policies +
Attendance Policy
Students must attend all regularly scheduled classes and enhancement rotations. The student is expected to be punctual and prepared for all lecture sessions. Reading assignments should be completed in advance of each lecture. Excused absence from class is to be avoided if at all possible, more than two will result in a warning notice. The Education Coordinator must be notified in the event of any absence scheduled or not.

Students are considered employees of the Johns Hopkins Hospital and as such work weekends, off-shifts, and holidays as well as accumulate Paid Time Off (PTO) at 6.77 hours per pay period. Time off for weekends worked is scheduled for the Friday before and the Monday after the weekend. The Lead Tech in charge of scheduling and the Education Coordinator MUST approve PTO for vacation time, including compensatory time, and time off for holidays worked. Prior approval must be obtained to be excused from a scheduled lecture or rotation. For all employees, PTO for illness will be used only in time of illness. Abuse of this time is cause for dismissal.

A maximum of ten absences is the allowed during the year, not including scheduled time off for weekend or holiday work. It is suggested that a student use vacation time sparingly in order to save some time for job interviews at the end of the year and to attend local and national professional meetings.

Unexcused absences and unsatisfactory participation are cause for dismissal. If unexpected circumstances should arise, the student is expected to notify the Education Coordinator and make arrangements to make up any missed rotation time.

Student Withdrawal or Dismissal
A student's matriculation through the JHH SBB Program may be terminated by two means, self-withdrawal and dismissal. Immediately after withdrawal or removal from the program, the AABB National Office will be notified.

Method for Removal of Students from the SBB Program

A. Cause for Removal
1. Failure to maintain an acceptable grade average as measured by examinations.
2. Failure to demonstrate understanding of didactic and technical theory evidenced by the student's inability to resolve serologic problems, select appropriate patient treatment methods, participate in an intellectual exchange or explain concepts that have been previously discussed.
3. Failure to regularly attend scheduled classes, seminars, meetings, and/ or failure to participate in an acceptable manner as determined by the Education Coordinator. Unexcused absences will not be tolerated.
4. Failure to follow the established hospital personnel policies and procedures as outlined in the hospital personnel handbook.
5. Failure to follow the TMD standard operating procedures.

B. Method of Removal
1. Failure to follow hospital policy under A-4 above can result in immediate dismissal. Since SBB students are employees, the dismissal method will follow the JHH Personnel Procedure. The Education Coordinator will participate in the evaluation of the student for dismissal.
2. Failure to follow the TMD standard operating procedures under A-5 above will result in a written warning. Since SBB students are employees, subsequent steps for dismissal will follow the JHH Personnel Procedure.
3. Failure to participate satisfactorily as outlined in A-1, 2, 3 above, can result in a student's removal from the program. Such action will be discussed and decided by the SBB faculty. The Education Coordinator will utilize both verbal and written warnings to notify the student of sub-standard performance. The warning notice will list the specific deficiencies or reasons the student's performance is considered sub-standard. The statement "Failure to demonstrate improvement can result in dismissal from the program." Will be included in the notice. A follow-up evaluation will take place no later than one month after the initial written warning notice. If the student fails to demonstrate improvement, they will be dismissed from the SBB program.
4. A student dismissed from the program for reasons listed in A-1, 2, 3 above may request to remain as an employee of the TMD. This decision rests with the Medical Director and Laboratory Manager.
5. A student may voluntarily withdraw from the program. To continue as an employee, the student will require the approval of the Medical Director and Laboratory Manager.
6. A student dismissed for reasons listed in A-4, 5 above will automatically be dismissed from the SBB program since the employment status is terminated.
7. Immediately after withdrawal or removal from the program, the AABB National Office will be notified.

C. Appeals Process
1. Dismissal for failure to follow JHH policy or TMD standard operating procedures may be appealed through the hospital's grievance procedure as outlined in the JHH Human Resources Policy and Procedure Manual.
2. Students dismissed from the Program for poor academic performance as outlined in A-1, 2, and 3 above will receive both verbal and written notice of dismissal. Students may appeal this decision by submitting in writing the reasons why they believe they should not be dismissed. The SBB Program Faculty will evaluate this appeal.
Support the Program +
Interested in donating to support the SBB program?
Thank you for your partnership! Donate online here by designating your gift to support "Other" from the dropdown and specifying Specialist in Blood Bank Technology Program. Thank you.
Graduates of SBB Program +

Patricia Eska
  • Winn, L. C., Eska, P. L. and Grindon, A. J. (1975), ABO Discrepancy Caused by an Auto Anti-N. Transfusion, 15: 612-613.
  • Winn, L. C., Eska, P. L. and Grindon, A. J. (1976), Anti-Rd (Radin) Following the Transfusion of a Radin Positive Unit of Blood. Transfusion, 16: 351-352.
  • Grindon, A. J. and Eska, P. L. (1977), Error Rate, Precision, and Accuracy in Immunohematology. Transfusion, 17: 425-430.


Sandra Alm Buck
Has 5 grandchildren
Second home in Vermont
Hobbies: running, biking, bridge, knitting and babysitting - not in that order.

Randi Passamaneck -
Spouse: Leonard Friedman
I am retired and keep active with extensive traveling, participating in two book clubs, working out at the Gym, and swimming. I am also the "Queen" of a local Red Hat Society Chapter, the Chic Red Hatters of Merry Land.

Patricia Wright -
I finally retired last year (2016) and now spend my time working with my Rotary Club, traveling, photography, fixing up my new home and exploring my new state, Delaware.


Christine Barrasso -

Sarah Haley Hixon, MT, (ASCP), SBB
The Johns Hopkins Hospital, SBB class 1973-74
Greenville Hospital System, Greenville, SC, 1974-1979
Carolina-Georgia Blood Center, Greenville, SC, 1979-1988
St Francis Hospital, Greenville, SC, 1988-1998
Retired and enjoying living in South Alabama.

Mary Ellen (Mel) Rosché -
Practice Management Analyst, Johns Hopkins University School of Medicine
Clinical Practice Association, Greenspring Station Foxleigh Building
Baltimore, MD

Ginny Tyler -

Linda C. Winn MA, MT(ASCP)SBB -
I am retired living in San Francisco, CA enjoying my passions of urban living, traveling and being a "foodie".
  • Winn, L. C., Eska, P. L. and Grindon, A. J. (1975), ABO Discrepancy Caused by an Auto Anti-N. Transfusion, 15: 612-613.
  • Winn, L. C., Eska, P. L. and Grindon, A. J. (1976), Anti-Rd (Radin) Following the Transfusion of a Radin Positive Unit of Blood. Transfusion, 16: 351-352.




Gilliam (Gill) Conley -
At the end of September, 2016, I retired from my position as the Director, Division of Inspections and Surveillance in FDA's Center for Biologics Evaluation and Research / Office of Compliance and Biologics Quality.



Evelyn Hunt

Sandra Nance -
Sr Director, Immunohematology Reference Laboratory
Biomedical Services
American Red Cross

Mary Adrian Vansickel -
Columbia, MD


JL Nina Salamon -
Executive Vice President, Blood Centers of America, Inc.
West Warwick, RI
  • Gibble JW, Salamon JL and Ness PM. Comparison of antibody elution techniques by enzyme linked antiglobulin test (ELAT). Transfusion, 23:300, 1983.
  • Ness PM, Salamon JL. The failure of post injection Rh immune globulin titers to detect large fetal maternal hemorrhages. American Journal of Clinical Pathology, 85-604, 1985.
  • Kickler TS, Salamon JL, Welsh F, Ness PM, Braine H. A microtiter plate technique for the detection of platelet antibodies and platelet antigen typing. Transfusion, 24:247, 1984.
  • Druzin ML, Wolf CFW, Eidersheim T, Hudon JM, Kogust EA, Salamon J. Donation of blood by the pregnant patient for autologous transfusion. American Journal of Obstetrics and Gynecology, 159:1023, 1988.


Donna Fitzpatrick MT(ASCP)SBB, CHS(ABHI) -
Retired in 2015 as Technical Director, Histocompatibility Laboratory
Massachusetts General Hospital
Boston, MA

Our laboratory supports the solid organ and hematopoietic stem cell transplant programs. We also do a lot of training of med tech students, pathology residents as well as various other transplant personnel. I was also involved with various research projects and participated in several team publications.
I'm still "de-stressing" and enjoying my summer cottage in Maine. I also keep busy with hiking and biking tours in the US and abroad and am currently living in Massachusetts.

Barbara Smith, MT(ASCP)SBB -
The Johns Hopkins Hospital (1977 to 1985, 2012 to present)
American Red Cross, Greater Chesapeake and Potomac Region (1998 to 1999)
Johns Hopkins University, School of Medicine (1986 to 2012)
  • Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL. 2004. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun. 324:269-275.
  • Walz T, Hirai T, Murata K, Heymann JB, Mitsuoka K, Fujiyoshi Y, Smith BL, Agre P, and Engel A. 1997. The three-dimensional structure of aquaporin-1. Nature. 387:624-627.
  • Smith BL, Preston GM, Spring FA, Anstee DJ, and Agre P. 1994. Human red cell Aquaporin CHIP: I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest. 94:1043-1049.
  • Smith BL, and Agre P. 1991. Erythrocyte Mr 28,000 transmembrane protein exists as a multisubunit oligomer similar to channel proteins. J Biol Chem. 266:6407-6415.
  • Denker BM, Smith BL, Kuhajda FP, and Agre P. 1988. Identification, purification, and partial characterization of a novel Mr 28,000 integral membrane protein from erythrocytes and renal tubules. J Biol Chem. 263:15634-15642.
  • Greenberg A, Winkler R, Smith BL, and Liebman J. 1982. The negatively charged nitrogen in ammonium ion and derived concepts of acidity, basicity, proton affinity, and ion energetics. J Chem Ed. 59:367-370.

Mary Beth Trich Spaeth, MAS, MT(ASCP)SBB
American Red Cross, Greater Chesapeake and Potomac Region, (1981 to present)
Immunohematology Reference Lab
Retired full-time in 2003; Work per-diem at present
Enjoy traveling, winter in Florida.


Janice Davis-Sproul, MAS, MT(ASCP)SBB -
Manager, Cell Therapy Laboratory
Technical Director, GMP Biologics Facility
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Johns Hopkins University School of Medicine Faculty Position: Research Associate
  • Noonan KA, Huff CA, Davis J, Lemas MV, Fiorino S, Bitzan J, Ferguson A, Emerling A, Luznik L, Matsui W, Powell J, Fuchs E, Rosner GL, Epstein C, Rudraraju L, Ambinder RF, Jones RJ, Pardoll D, Borrello I. Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. Sci Transl Med. 2015 May 20;7(288):288ra78. PMCID: 25995224
  • Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zambrano JP, Fishman J, Pattany P, McNiece I, Conte J, Schulman S, Wu K, Shah A, Breton E, Davis-Sproul J, Schwarz R, Feigenbaum G, Mushtaq M, Suncion VY, Lardo AC, Borrello I, Mendizabal A, Karas TZ, Byrnes J, Lowery M, Heldman AW, Hare JM. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circulation research. 2014;114(8): 1302-10. PMCID: 4104798.

Janis F. Smith, MAS, MT(ASCP)SBB -
Administrative Director, Pathology and Laboratory Medicine
Greater Baltimore Medical Center
Baltimore, MD


Senior Director, Technical Services
Community Blood Center, an affiliate of New York Blood Center
Kansas City, MO


Sandra Thoman
Supervisor, Transfusion Medicine
The Johns Hopkins Hospital
Baltimore, MD


Gail S. Freund MT(ASCP)SBB
IRL Technologist, Reference Lab
American Red Cross, Massachusetts Region
Dedham MA


Kevin B. Lawton MT(ASCP)SBB -
Transfusion Service Supervisor
MedStar Harbor Hospital
Previous employment:
The Johns Hopkins Hospital, Baltimore, Maryland. Medical Technologist. Blood Bank. (1978 to 1985)
The Johns Hopkins Hospital, Baltimore, Maryland. Specialist in Blood Banking Program. (1985 to 1986)
The Johns Hopkins Hospital, Baltimore, Maryland. Lead Technologist. Blood Bank. (1986 to 1988)
The University of Maryland Medical System, Baltimore, Maryland. Clinical Laboratory Supervisor, Blood Bank. (1988 to 1998)
MedStar Harbor Hospital Center, Baltimore, Maryland. Clinical Laboratory Supervisor, Transfusion Service. (1998 to present)


Bernadette Graves, MT(ASCP)SBB
Johns Hopkins SBB class 1986-87
St. Joseph Hospital, Omaha, NE
    -Manager, Transfusion Service (1987-1993)
Community Blood Center of Greater Kansas City
Kansas City, MO
    -IRL Tech (1993-2003)
    -Lead IRL Tech (2003-present)

Jane Mills, MT(ASCP)SBB
Howard County general Hospital 1987-1996
Reference Technologist American Red Cross 1996-January 2017
Volunteer in IRL at American Red Cross January 2017-present
Over the next six month, I will be moving to Wilmington Delaware

Anita Richardson, MAS -
Center for Biologics Evaluation and Research (1990 to present)
Office of Compliance and Biologics Quality
U.S. Food and Drug Administration



Suzy Nicol, MS, MT(ASCP)SBB -
Pathology Laboratory Manager II, Johns Hopkins Bayview Medical Center (2005-present)
The Johns Hopkins Hospital (1993-present)
Baltimore, MD

Roxanne M. Tata, MT(ASCP) SBB; CQA(ASQ) -
Senior Corporate Director Quality
Bloodsystems, Inc.


Joan Boyd
Manager, Transfusion Medicine
The Johns Hopkins Hospital
Baltimore, MD



William M. Montgomery, Jr., MT(ASCP)SBB -
Quality Assurance Technologist
The Johns Hopkins Hospital
Transfusion Medicine Division


Nanette C. Johnson, MT(ASCP)SBB -
Director, IRL
American Red Cross of the Greater Chesapeake and Potomac Blood Services Region
Baltimore, MD

William Turcan - /
Program Director, Blood Bank Fellowship
Walter Reed National Military Medical Center
Bethesda, MD



Donna Marquess, FACHE, MA, MT(ASCP), SBB, DLM -
Assistant Vice President, Laboratory Services
LifeBridge Health Laboratories
Sinai Hospital of Baltimore
Northwest Hospital
Carroll Hospital
Levindale Hebrew Geriatric Center and Hospital

Gerald Rogalski MSc, PMP, MT(ASCP)SBB
Lead IT, Regional Systems Support
Roche Support Network


Donna Mirabella MS, MT(ASCP)SBB -
Associate Technical Director, Blood Bank
Stony Brook University Medical Center
Stony Brook, NY
  • Shirey, R.S., Mirabella, D.C., Lumadue, J.A. and Ness, P.M. (1997), Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies. Transfusion, 37: 493-496.
  • Velliquette, R.W., Hu, Z., Lomas-Francis, C., Hue-Roye, K., Allen, J.L., Mirabella, D. and Reid, M.E. (2010), Novel single-nucleotide change in GYP*A in a person who made an alloantibody to a new high-prevalence MNS antigen called ENEV. Transfusion, 50: 856-860.
  • David M Nguyen, MD, Hun J Lee, MD, Donna Mirabella, MT(ASCP) SBB, Ding Wen Wu, MD, PhD Delayed Hemolytic Transfusion Reaction due to Anti-Jkb: Case Report Highlighting the Importance of Early Blood Bank Consultation and Literature Review North American Journal of Medicine and Science Oct 2010 Vol 3 No.4 187


Parveen F. Halim MT(ASCP) -
Lead Technologist, American Red Cross, IRL
Previous Employment:
Pascack Valley Hospital (1996-1999)
    -Medical Technologist, Generalist
The Johns Hopkins Hospital (2000-2006)
    -Technologist, Transfusion Medicine
    -Lead Tech, Transfusion Medicine
American Red Cross, IRL (2006-present)
Baltimore, MD
    -Technologist II
    -Technologist III
    -Lead Technologist


Lorraine Blagg, MA, MLS(ASCP)CMSBB -
Education & Development Coordinator, Transfusion Medicine Division
Program Director, Specialist in Blood Bank Technology Program
The Johns Hopkins Hospital (2001-present)
Assistant Editor, Transfusion News (2016-present)
  • Bell MJ, Stockwell DC, Luban NL, Shirey RS, Shaak L, Ness PM, Wong EC. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease. Pediatr Crit Care Med. 2005 May;6(3):363-6.
  • Blagg LN. Transfusion Science, 2nd ed. Joyce Overfield, Maureen Dawson, and David Hamer. Oxfordshire , Scion Publishing Ltd , 2008. (book review). Transfusion 2010; 50: 2281.
  • Eipl K, Nakabiito C, Bwogi K, Motevalli M, Roots A, Blagg L, and Jackson, JB. Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda. Immunohematology 2012;28:115-117.
  • Karafin MS, Blagg L, Tobian AAR, King KE, Ness PM, and Savage WJ. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion, 2012 Oct; 52(10): 2087-2093.


Rosalinda "Leny" M. Catamisan, CLS (California), SBB(ASP)CM -
Blood Bank Manager-Transfusion Service & Blood Donor Center
Torrance Memorial Medical Center
Torrance, CA


The Johns Hopkins Hospital
Microbiology (2003-2004)
Blood Bank Technologist/Lead Tech, Transfusion Medicine (2004-present)
Baltimore, MD

Penn State Health, Milton S Hershey Medical Center (2016-present)
Chief Technologist Blood Bank
Interim Manager Pathology & Lab Medicine- Laboratory Administration
Hershey, PA


Supervisor, Transfusion Service
Stanford Health Care
  • Shirey, R. S., Cai, W., Montgomery, R. A., Chhibber, V., Ness, P. M. and King, K. E. (2010), IMMUNOHEMATOLOGY: Streamlining ABO antibody titrations for monitoring ABO-incompatible kidney transplants. Transfusion, 50: 631-634.



Read the Blog

Alissa B. Ducharme, MLS(ASCP)CMSBBCM
Medical Technologist
St. Agnes Hospital
Baltimore, MD

Heather Smetana
Technical Specialist, Transfusion Medicine
The Johns Hopkins Hospital
Baltimore, MD
  • Smith, H.M., Shirey, R.S., Thoman, S.K., and Jackson, J.B. (2013), Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology, 29: 127-130.

Read the Blog

Rebecca Perry Coward, BS, MT(ASCP)SBBCM
Supervisor, Transfusion Services
WakeMed Raleigh Campus (2016-present)
Raleigh, NC
2013 Suzanne Ledin Travel Award

Read the Blog

E. Nadjay Cambre MLS(ASCP)CMSBBCM -
Lead Tech, Transfusion Medicine
The Johns Hopkins Hospital (2012-present)
Baltimore, MD

Read the Blog

Clinical Laboratory Scientist, Transfusion Medicine
The Johns Hopkins Hospital
Baltimore, MD

Read the Blog

Chief Technologist, Blood Bank
Penn State Health, Milton S Hershey Medical Center
Hershey, PA
  • Erony, S. M., Marshall, C. E., Gehrie, E. A., Boyd, J. S., Ness, P. M., Tobian, A. A., Carroll, K. C., Blagg, L. , Shifflett, L. and Bloch, E. M. (2018), The epidemiology of bacterial cultureâpositive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016. Transfusion, 58: 1933-1939.

  • Lokhandwala, P.M., O'Neal, A., Patel, E.U., Brunker, P.A., Gehrie, E.A., Zheng, G., Kickler, T.S., Ness, P.M. and Tobian, A.A. (2018), Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Transfusion, 58: 1126-1131.
Read the Blog

Clinical Laboratory Scientist, Transfusion Medicine
The Johns Hopkins Hospital
Baltimore, MD
2018 AABB Future Leader, Specialty in Blood Banking Scholarship Award
  • Haddaway, K., Bloch, E.M., Tobian, A.A., Frank, S.M., Sikorski, R., Cho, B.C., Zheng, G., Jani, J., Lokhandwala, P.M., Lawrence, C.E., Blagg, L., Ness, P.M., Kickler, T.S. and Gehrie, E.A. (2019), Hemostatic properties of cold-stored whole blood leukoreduced using a platelet-sparing versus a non-platelet-sparing filter. Transfusion.

Commission on Accreditation of Allied Health Education Programs